QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Prime Medicine (PRME) News Today

$8.66
+0.34 (+4.09%)
(As of 02/26/2024 ET)
SourceHeadline
marketbeat.com logo128,876 Shares in Prime Medicine, Inc. (NYSE:PRME) Acquired by Rafferty Asset Management LLC
marketbeat.com - February 24 at 5:34 AM
finance.yahoo.com logoPRME Mar 2024 12.500 call
finance.yahoo.com - February 23 at 8:16 AM
MarketBeat logoPrime Medicine (NYSE:PRME) Shares Gap Up After Insider Buying Activity
americanbankingnews.com - February 22 at 1:22 AM
MarketBeat logoPrime Medicine, Inc. (NYSE:PRME) Director Robert Nelsen Purchases 3,200,000 Shares
americanbankingnews.com - February 21 at 4:20 AM
globenewswire.com logoPrime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
globenewswire.com - February 20 at 4:01 PM
MarketBeat logoPrime Medicine (NYSE:PRME) Trading 5.5% Higher
americanbankingnews.com - February 18 at 3:40 AM
MarketBeat logoAnalysts Set Prime Medicine, Inc. (NYSE:PRME) PT at $18.14
americanbankingnews.com - February 18 at 1:52 AM
marketbeat.com logoPrime Medicine (NYSE:PRME) Trading Up 5.5%
marketbeat.com - February 16 at 11:54 AM
finanznachrichten.de logoPrime Medicine, Inc.: Prime Medicine Announces Pricing of Upsized Public Offering
finanznachrichten.de - February 15 at 1:34 PM
msn.com logoPrime Medicine down 5%, prices $140M stock offering
msn.com - February 15 at 8:33 AM
marketbeat.com logoPrime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Brokerages
marketbeat.com - February 15 at 5:12 AM
finance.yahoo.com logoPrime Medicine Announces Pricing of Upsized Public Offering
finance.yahoo.com - February 15 at 1:15 AM
globenewswire.com logoPrime Medicine Announces Pricing of Upsized Public Offering
globenewswire.com - February 14 at 11:50 PM
finance.yahoo.com logoPrime Medicine Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 14 at 8:15 PM
globenewswire.com logoPrime Medicine Announces Proposed Public Offering of Common Stock
globenewswire.com - February 14 at 4:05 PM
marketbeat.com logoPrime Medicine (NYSE:PRME) Trading Down 8.4%
marketbeat.com - February 13 at 1:32 PM
finance.yahoo.com logoPrime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
finance.yahoo.com - February 1 at 8:33 AM
marketbeat.com logoGreenwich Wealth Management LLC Acquires 231,021 Shares of Prime Medicine, Inc. (NYSE:PRME)
marketbeat.com - January 29 at 11:49 AM
seekingalpha.com logoPrime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing
seekingalpha.com - January 28 at 9:14 AM
finance.yahoo.com logoPrime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
finance.yahoo.com - January 25 at 8:15 AM
marketbeat.com logo2 gene editing stocks to keep on your 2024 watchlist (PRME)
marketbeat.com - January 23 at 8:23 AM
uk.finance.yahoo.com logoFirst Trust Heitman Glbl Prm Rl Estt ETF (PRME)
uk.finance.yahoo.com - January 22 at 10:14 AM
marketbeat.com logoPrime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Analysts
marketbeat.com - January 21 at 6:17 AM
marketbeat.com logoSumitomo Mitsui Trust Holdings Inc. Boosts Stock Holdings in Prime Medicine, Inc. (NYSE:PRME)
marketbeat.com - January 18 at 5:55 AM
msn.com logoStifel cuts Prime Medicine to hold, cites quieter catalyst outlook
msn.com - January 16 at 7:42 PM
marketbeat.com logoPrime Medicine (NYSE:PRME) Cut to Hold at Stifel Nicolaus
marketbeat.com - January 16 at 8:28 AM
realmoney.thestreet.com logoPrime Medicine just downgraded at Stifel, here's why
realmoney.thestreet.com - January 16 at 12:00 AM
finance.yahoo.com logoWall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know
finance.yahoo.com - January 9 at 11:13 PM
finance.yahoo.com logoPrime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes
finance.yahoo.com - January 5 at 6:16 PM
markets.businessinsider.com logoPrime Medicine Names Allan Reine New CFO
markets.businessinsider.com - January 5 at 1:12 PM
finance.yahoo.com logoPrime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
finance.yahoo.com - January 5 at 8:11 AM
marketbeat.com logoPrime Medicine, Inc. (NYSE:PRME) Given Average Rating of "Moderate Buy" by Brokerages
marketbeat.com - December 27 at 6:17 AM
fool.com logoBetter Growth Stock: Archer Aviation or Prime Medicine?
fool.com - December 19 at 1:17 PM
morningstar.com logoPrime Medicine Inc PRME
morningstar.com - December 9 at 10:02 PM
msn.com logoCitigroup Initiates Coverage of Prime Medicine (PRME) with Neutral Recommendation
msn.com - December 9 at 1:58 AM
realmoney.thestreet.com logoPrime Medicine initiated with neutral view at Citi, here's why
realmoney.thestreet.com - December 8 at 10:04 AM
markets.businessinsider.com logoPrime Medicine’s Promising Outlook: Buy Rating Justified by Preclinical Success, Potential Partnerships, and Healthy Financials
markets.businessinsider.com - November 8 at 1:51 PM
forbes.com logoAmazon Announces New Benefit For Prime Members: Primary Care Services For $9 Per Month
forbes.com - November 8 at 7:47 AM
benzinga.com logoPrime Medicine Stock (NASDAQ:PRME), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 7 at 9:46 PM
msn.com logoPrime Medicine files for $500M mixed shelf
msn.com - November 5 at 5:31 AM
finanznachrichten.de logoPrime Medicine, Inc.: Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
finanznachrichten.de - November 4 at 10:49 AM
finance.yahoo.com logoPrime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - November 3 at 5:30 PM
finance.yahoo.com logoPrime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases
finance.yahoo.com - October 24 at 8:55 AM
usatoday.com logoWhat to know about Amazon Prime Big Deal Days: The October 2023 sale is here
usatoday.com - October 15 at 8:00 AM
businessinsider.com logoHow to get an Amazon Prime free trial: First-time subscribers can try before they buy for 30 days
businessinsider.com - October 10 at 8:09 PM
nasdaq.com logoBMO Capital Initiates Coverage of Prime Medicine (PRME) with Outperform Recommendation
nasdaq.com - October 9 at 6:00 PM
markets.businessinsider.com logoAnalyst Ratings for Prime Medicine
markets.businessinsider.com - October 9 at 1:00 PM
markets.businessinsider.com logoPrime Medicine’s Prospective Growth Driven by Superior Gene Editing Technology and Potential Treatments for High Unmet-Need Indications
markets.businessinsider.com - October 9 at 7:59 AM
msn.com logoEarly Prime Day deals on household items worth stocking up on
msn.com - October 8 at 9:44 AM
seekingalpha.com logoPrime Medicine: Not Yet Primed For Retail Investment
seekingalpha.com - September 27 at 8:49 AM
Get Prime Medicine News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter.



PRME Media Mentions By Week

PRME Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRME
News Sentiment

0.82

0.45

Average
Medical
News Sentiment

PRME News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRME Articles
This Week

6

1

PRME Articles
Average Week

Get Prime Medicine News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:PRME) was last updated on 2/26/2024 by MarketBeat.com Staff